The value of APTw CEST MRI in routine clinical assessment of human brain tumor patients at 3T

Background. With fast-growing evidence in literature for clinical applications of chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI), this prospective study aimed at applying amide proton transfer-weighted (APTw) CEST imaging in a clinical setting to assess its diagnostic...

Full description

Saved in:
Bibliographic Details
Main Authors: Lingl, Julia (Author) , Wunderlich, Arthur (Author) , Görke, Steffen (Author) , Paech, Daniel (Author) , Ladd, Mark E. (Author) , Liebig, Patrick (Author) , Pala, Andrej (Author) , Kim, Soung Yung (Author) , Braun, Michael (Author) , Schmitz, Bernd (Author) , Beer, Meinrad (Author) , Rosskopf, Johannes (Author)
Format: Article (Journal)
Language:English
Published: 14 February 2022
In: Diagnostics
Year: 2022, Volume: 12, Issue: 2, Pages: 1-11
ISSN:2075-4418
DOI:10.3390/diagnostics12020490
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/diagnostics12020490
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2075-4418/12/2/490
Get full text
Author Notes:Julia P. Lingl, Arthur Wunderlich, Steffen Goerke, Daniel Paech, Mark E. Ladd, Patrick Liebig, Andrej Pala, Soung Yung Kim, Michael Braun, Bernd L. Schmitz, Meinrad Beer and Johannes Rosskopf
Description
Summary:Background. With fast-growing evidence in literature for clinical applications of chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI), this prospective study aimed at applying amide proton transfer-weighted (APTw) CEST imaging in a clinical setting to assess its diagnostic potential in differentiation of intracranial tumors at 3 tesla (T). Methods. Using the asymmetry magnetization transfer ratio (MTRasym) analysis, CEST signals were quantitatively investigated in the tumor areas and in a similar sized region of the normal-appearing white matter (NAWM) on the contralateral hemisphere of 27 patients with intracranial tumors. Area under curve (AUC) analyses were used and results were compared to perfusion-weighted imaging (PWI). Results. Using APTw CEST, contrast-enhancing tumor areas showed significantly higher APTw CEST metrics than contralateral NAWM (AUC = 0.82; p < 0.01). In subgroup analyses of each tumor entity vs. NAWM, statistically significant effects were yielded for glioblastomas (AUC = 0.96; p < 0.01) and for meningiomas (AUC = 1.0; p < 0.01) but not for lymphomas as well as metastases (p > 0.05). PWI showed results comparable to APTw CEST in glioblastoma (p < 0.01). Conclusions. This prospective study confirmed the high diagnostic potential of APTw CEST imaging in a routine clinical setting to differentiate brain tumors.
Item Description:Gesehen am 05.05.2022
Physical Description:Online Resource
ISSN:2075-4418
DOI:10.3390/diagnostics12020490